Source link : https://www.newshealth.biz/health-news/fda-oks-sarilumab-for-polyarticular-jia/
The US Food and Drug Administration (FDA) has approved sarilumab (Kevzara) for the treatment of polyarticular juvenile idiopathic arthritis (pJIA) for patients weighing ≥ 63 kg (139 lb). “Polyarticular juvenile idiopathic arthritis (JIA) can be a painful disease for children where multiple joints are impacted by this chronic inflammation,” said George D. Yancopoulos, MD, PhD, […]
Author : News Health
Publish date : 2024-06-11 19:07:27
Copyright for syndicated content belongs to the linked Source.
Categories